SlowBull
The Business Brief TUESDAY, 1 SEPTEMBER 2026
← All stories
Markets

Could Probiotics Improve GLP-1 Treatment? This Living Drug Responds to Blood Sugar

1 source ·1 article ·1h ago

Researchers engineered a probiotic to sense glucose spikes and release GLP-1 on demand. It worked in diabetic mice and monkeys, but human trials remain ahead.

Covered by 1 outlet

Inc 1

All coverage · 1 article

Inc. Magazine ·1h ago

Could Probiotics Improve GLP-1 Treatment? This Living Drug Responds to Blood Sugar

Researchers engineered a probiotic to sense glucose spikes and release GLP-1 on demand. It worked in diabetic mice and monkeys, but human trials remain ahead.